Cellular mechanisms of CCL22-mediated attenuation of autoimmune diabetes

Journal of Immunology

Volumn 194, Issue 7, 2015, Pages 3054-3064

  Bischoff, Loraine ^a   Alvarez, Sigrid ^a   Dai, Derek L ^a   Soukhatcheva, Galina ^a   Orban, Paul C ^a   Verchere, C Bruce ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE DERIVED CHEMOKINE; INDOLEAMINE 2,3 DIOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL ASSAY; CELL FUNCTION; CELL LEVEL; CELL TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; FEMALE; IN VITRO STUDY; MOLECULAR DYNAMICS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; ANIMAL; CHEMOTAXIS; DENDRITIC CELL; DISEASE MODEL; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; NATURAL KILLER T CELL; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION;

ANIMALS; CHEMOKINE CCL22; CHEMOTAXIS; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; IMMUNOMODULATION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSDUCTION, GENETIC; TRANSPLANTS;

EID: 84925849735     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400567     Document Type: Article

References (67)

1. Vulcano, M., C. Albanesi, A. Stoppacciaro, R. Bagnati, G. D'Amico, S. Struyf, P. Transidico, R. Bonecchi, A. Del Prete, P. Allavena, et al. 2001. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur. J. Immunol. 31: 812-822.
2. Mailloux, A. W., and M. R. Young. 2009. NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment. J. Immunol. 182: 2753-2765.
3. Mantovani, A., P. A. Gray, J. Van Damme, and S. Sozzani. 2000. Macrophage-derived chemokine (MDC). J. Leukoc. Biol. 68: 400-404.
4. + regulatory T cells in gastric cancer. Int. J. Cancer 122: 2286-2293.
5. Gobert, M., I. Treilleux, N. Bendriss-Vermare, T. Bachelot, S. Goddard-Leon, V. Arfi, C. Biota, A. C. Doffin, I. Durand, D. Olive, et al. 2009. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 69: 2000-2009.
6. Qin, X. J., H. Z. Shi, J. M. Deng, Q. L. Liang, J. Jiang, and Z. J. Ye. 2009. CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin. Cancer Res. 15: 2231-2237.
7. Curiel, T. J., G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J. R. Conejo-Garcia, L. Zhang, M. Burow, et al. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10: 942-949.
8. Riezu-Boj, J. I., E. Larrea, R. Aldabe, L. Guembe, N. Casares, E. Galeano, I. Echeverria, P. Sarobe, I. Herrero, B. Sangro, et al. 2011. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection. J. Hepatol. 54: 422-431.
9. Nakayama, T., K. Hieshima, D. Nagakubo, E. Sato, M. Nakayama, K. Kawa, and O. Yoshie. 2004. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J. Virol. 78: 1665-1674.
10. Montane, J., L. Bischoff, G. Soukhatcheva, D. L. Dai, G. Hardenberg, M. K. Levings, P. C. Orban, T. J. Kieffer, R. Tan, and C. B. Verchere. 2011. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. J. Clin. Invest. 121: 3024-3028.
11. Montane, J., M. Obach, S. Alvarez, L. Bischoff, D. L. Dai, G. Soukhatcheva, J. J. Priatel, G. Hardenberg, M. K. Levings, R. Tan, et al. 2014. CCL22 prevents rejection of mouse islet allografts and induces donor-specific tolerance. Cell Transplant. In press.
12. Contento, R. L., B. Molon, C. Boularan, T. Pozzan, S. Manes, S. Marullo, and A. Viola. 2008. CXCR4-CCR5: a couple modulating T cell functions. Proc. Natl. Acad. Sci. USA 105: 10101-10106.
13. Karpus, W. J., N. W. Lukacs, K. J. Kennedy, W. S. Smith, S. D. Hurst, and T. A. Barrett. 1997. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 158: 4129-4136.
14. Lukacs, N. W., S. W. Chensue, W. J. Karpus, P. Lincoln, C. Keefer, R. M. Strieter, and S. L. Kunkel. 1997. C-C chemokines differentially alter interleukin-4 production from lymphocytes. Am. J. Pathol. 150: 1861-1868.
15. H2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404: 407-411.
16. Molon, B., G. Gri, M. Bettella, C. Gómez-Moutón, A. Lanzavecchia, C. Martínez-A, S. Mañes, and A. Viola. 2005. T cell costimulation by chemokine receptors. Nat. Immunol. 6: 465-471.
17. Ishii, M., C. M. Hogaboam, A. Joshi, T. Ito, D. J. Fong, and S. L. Kunkel. 2008. CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling. Eur. J. Immunol. 38: 2290-2302.
18. Pinho, V., S. H. Oliveira, D. G. Souza, D. Vasconcelos, A. L. Alessandri, N. W. Lukacs, and M. M. Teixeira. 2003. The role of CCL22 (MDC) for the recruitment of eosinophils during allergic pleurisy in mice. J. Leukoc. Biol. 73: 356-362.
19. + regulatory T cells. J. Immunol. 185: 183-189.
20. Salvalaggio, P. R., S. Deng, C. E. Ariyan, I. Millet, W. S. Zawalich, G. P. Basadonna, and D. M. Rothstein. 2002. Islet filtration: a simple and rapid new purification procedure that avoids ficoll and improves islet mass and function. Transplantation 74: 877-879.
21. D'Ambrosio, D., A. Iellem, R. Bonecchi, D. Mazzeo, S. Sozzani, A. Mantovani, and F. Sinigaglia. 1998. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J. Immunol. 161: 5111-5115.
22. Morimoto, Y., Y. Bian, P. Gao, Y. Yashiro-Ohtani, X. Y. Zhou, S. Ono, H. Nakahara, M. Kogo, T. Hamaoka, and H. Fujiwara. 2005. Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development. J. Leukoc. Biol. 78: 753-761.
23. + NKT cell subsets with distinct cytokine-producing capacity. Blood 100: 11-16.
24. Vecchi, A., L. Massimiliano, S. Ramponi, W. Luini, S. Bernasconi, R. Bonecchi, P. Allavena, M. Parmentier, A. Mantovani, and S. Sozzani. 1999. Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells. J. Leukoc. Biol. 66: 489-494.
25. Sozzani, S., W. Luini, A. Borsatti, N. Polentarutti, D. Zhou, L. Piemonti, G. D'Amico, C. A. Power, T. N. Wells, M. Gobbi, et al. 1997. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J. Immunol. 159: 1993-2000.
26. Inngjerdingen, M., B. Damaj, and A. A. Maghazachi. 2000. Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J. Immunol. 164: 4048-4054.
27. Hokari, R., S. Miura, H. Fujimori, S. Koseki, Y. Tsuzuki, H. Kimura, H. Higuchi, H. Serizawa, D. N. Granger, and H. Ishii. 1999. Altered migration of gut-derived T lymphocytes after activation with concanavalin A. Am. J. Physiol. 277: G763-G772.
28. Kesherwani, V., and A. Sodhi. 2007. Differential activation of macrophages in vitro by lectin concanavalin A, phytohemagglutinin and wheat germ agglutinin: production and regulation of nitric oxide. Nitric Oxide 16: 294-305.
29. Kaneko, Y., M. Harada, T. Kawano, M. Yamashita, Y. Shibata, F. Gejyo, T. Nakayama, and M. Taniguchi. 2000. Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191: 105-114.
30. Bottino, R., A. N. Balamurugan, H. Tse, C. Thirunavukkarasu, X. Ge, J. Profozich, M. Milton, A. Ziegenfuss, M. Trucco, and J. D. Piganelli. 2004. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 53: 2559-2568.
31. Mokhtari, D., T. Li, T. Lu, and N. Welsh. 2011. Effects of imatinib mesylate (Gleevec) on human islet NF-κB activation and chemokine production in vitro. PLoS ONE 6: e24831.
32. Sebastiani, S., G. Danelon, B. Gerber, and M. Uguccioni. 2005. CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first β-strand of chemokine. Eur. J. Immunol. 35: 746-756.
33. Lehuen, A., J. Diana, P. Zaccone, and A. Cooke. 2010. Immune cell crosstalk in type 1 diabetes. Nat. Rev. Immunol. 10: 501-513.
34. Thomas, H. E., J. A. Trapani, and T. W. Kay. 2010. The role of perforin and granzymes in diabetes. Cell Death Differ. 17: 577-585.
35. Aktas, E., U. C. Kucuksezer, S. Bilgic, G. Erten, and G. Deniz. 2009. Relationship between CD107a expression and cytotoxic activity. Cell. Immunol. 254: 149-154.
36. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21: 305-334.
37. Chappert, P., and R. H. Schwartz. 2010. Induction of T cell anergy: integration of environmental cues and infectious tolerance. Curr. Opin. Immunol. 22: 552-559.
38. + regulatory T cells in islets of nonobese diabetic mice. J. Immunol. 188: 1064-1074.
39. Fallarino, F., U. Grohmann, K. W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, M. L. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4: 1206-1212.
40. Hwang, S. L., N. P. Chung, J. K. Chan, and C. L. Lin. 2005. Indoleamine 2,3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines. Cell Res. 15: 167-175.
41. Sharif, S., G. A. Arreaza, P. Zucker, Q. S. Mi, J. Sondhi, O. V. Naidenko, M. Kronenberg, Y. Koezuka, T. L. Delovitch, J. M. Gombert, et al. 2001. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 7: 1057-1062.
42. Duarte, N., M. Stenström, S. Campino, M. L. Bergman, M. Lundholm, D. Holmberg, and S. L. Cardell. 2004. Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells. J. Immunol. 173: 3112-3118.
43. Shi, F. D., M. Flodstrom, B. Balasa, S. H. Kim, K. Van Gunst, J. L. Strominger, S. B. Wilson, and N. Sarvetnick. 2001. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc. Natl. Acad. Sci. USA 98: 6777-6782.
44. + T cells to the spleen during the generation of regulatory T cells in tolerance. J. Immunol. 169: 31-38.
45. Diana, J., V. Brezar, L. Beaudoin, M. Dalod, A. Mellor, A. Tafuri, M. von Herrath, C. Boitard, R. Mallone, and A. Lehuen. 2011. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay. J. Exp. Med. 208: 729-745.
46. Novak, J., and A. Lehuen. 2011. Mechanism of regulation of autoimmunity by iNKT cells. Cytokine 53: 263-270.
47. Collombat, P., X. Xu, P. Ravassard, B. Sosa-Pineda, S. Dussaud, N. Billestrup, O. D. Madsen, P. Serup, H. Heimberg, and A. Mansouri. 2009. The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 138: 449-462.
48. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199: 1479-1489.
49. + regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204: 191-201.
50. + regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA 101(Suppl. 2): 14580-14585.
51. Mellor, A. L., and D. H. Munn. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774.
52. Fallarino, F., U. Grohmann, C. Vacca, R. Bianchi, C. Orabona, A. Spreca, M. C. Fioretti, and P. Puccetti. 2002. T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9: 1069-1077.
53. Johnson, B. A., III, B. Baban, and A. L. Mellor. 2009. Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy. Immunotherapy 1: 645-661.
54. Fallarino, F., C. Volpi, T. Zelante, C. Vacca, M. Calvitti, M. C. Fioretti, P. Puccetti, L. Romani, and U. Grohmann. 2009. IDO mediates TLR9-driven protection from experimental autoimmune diabetes. J. Immunol. 183: 6303-6312.
55. Onodera, T., M. H. Jang, Z. Guo, M. Yamasaki, T. Hirata, Z. Bai, N. M. Tsuji, D. Nagakubo, O. Yoshie, S. Sakaguchi, et al. 2009. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions. J. Immunol. 183: 5608-5614.
56. Novak, J., L. Beaudoin, S. Park, T. Griseri, L. Teyton, A. Bendelac, and A. Lehuen. 2007. Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression. J. Immunol. 178: 1332-1340.
57. + regulatory T cells. J. Immunol. 177: 3695-3704.
58. Hongo, D., X. Tang, S. Dutt, R. G. Nador, and S. Strober. 2012. Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants. Blood 119: 1581-1589.
59. Kohrt, H. E., A. B. Pillai, R. Lowsky, and S. Strober. 2010. NKT cells, Treg, and their interactions in bone marrow transplantation. Eur. J. Immunol. 40: 1862-1869.
60. Saxena, V., J. K. Ondr, A. F. Magnusen, D. H. Munn, and J. D. Katz. 2007. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J. Immunol. 179: 5041-5053.
61. Nikolic, T., J. M. Welzen-Coppens, P. J. Leenen, H. A. Drexhage, and M. A. Versnel. 2009. Plasmacytoid dendritic cells in autoimmune diabetes: potential tools for immunotherapy. Immunobiology 214: 791-799.
62. Beaudoin, L., J. Diana, L. Ghazarian, Y. Simoni, C. Boitard, and A. Lehuen. 2014. Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes. Eur. J. Immunol. 44: 1454-1466.
63. Andrew, D. P., M. S. Chang, J. McNinch, S. T. Wathen, M. Rihanek, J. Tseng, J. P. Spellberg, and C. G. Elias, III. 1998. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J. Immunol. 161: 5027-5038.
64. Ronchi, F., and M. Falcone. 2008. Immune regulation by invariant NKT cells in autoimmunity. Front. Biosci. 13: 4827-4837.
65. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
66. Jiang, X., S. Kojo, M. Harada, N. Ohkohchi, M. Taniguchi, and K. I. Seino. 2007. Mechanism of NKT cell-mediated transplant tolerance. Am. J. Transplant. 7: 1482-1490.
67. Walsh, P. T., D. K. Taylor, and L. A. Turka. 2004. Tregs and transplantation tolerance. J. Clin. Invest. 114: 1398-1403.